Cellular Metabolism and Bioenergetic Function in Human Fibroblasts and Preadipocytes of Type 2 Familial Partial Lipodystrophy
LMNA mutation is associated with type-2 familial partial lipodystrophy (<i>FPLD2</i>). The disease causes a disorder characterized by anomalous accumulation of body fat in humans. The dysfunction at the molecular level is triggered by a lamin A/C mutation, impairing the cell metabolism....
Main Authors: | Cristina Algieri, Chiara Bernardini, Fabiana Trombetti, Elisa Schena, Augusta Zannoni, Monica Forni, Salvatore Nesci |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/15/8659 |
Similar Items
-
Familial Partial Lipodystrophy (FPLD): Recent Insights
by: Bagias C, et al.
Published: (2020-05-01) -
Evaluation of human dermal fibroblasts directly reprogrammed to adipocyte-like cells as a metabolic disease model
by: Jian-Hua Chen, et al.
Published: (2017-12-01) -
Partial lipodystrophy of limbs in type 2 diabetes: A case report
by: Meet Shah, et al.
Published: (2021-01-01) -
Rare Diagnosis of Familial Partial Lipodystrophy in a Patient With Life-Threatening Pancreatitis due to Hypertriglyceridemia
by: Chukwuka Akamnonu, MD, et al.
Published: (2022-01-01) -
Notch intracellular domain overexpression in adipocytes confers lipodystrophy in mice
by: Dionysios V. Chartoumpekis, et al.
Published: (2015-07-01)